MAAT
MaaT Pharma
Stock Euronext / Paris – Stock Market Prices, News & Analysis
MaaT Pharma is a biopharmaceutical company specializing in the development of microbial therapies for the treatment of serious diseases.
MaaT Pharma
MAAT
MaaT Pharma is a biopharmaceutical company specializing in the development of microbial therapies for the treatment of serious diseases.
Price history of MaaT Pharma
Price history of MaaT Pharma
Performance & Momentum
MaaT Pharma Reports Promising Clinical and Q3 Results
MaaT Pharma announced significant progress, including positive Phase 3 results for Xervyteg® in acute graft-versus-host disease presented at the ASH 2025 conference. The company also released updated preclinical data showing immune activation and promising antitumor activity for its candidate MaaT034. Additionally, MaaT Pharma published its Q3 2025 financial results along with a financing update. These developments boost confidence in the company’s clinical pipeline and could support medium-term investor interest.
Strategic Analysis
MaaT Pharma • 2026
MaaT Pharma positions itself in an innovative niche by developing microbiotic therapies targeting severe pathologies, a sector with strong therapeutic potential. Its model relies on advanced biotechnology research, aiming to leverage the microbiome to address unmet medical needs.
Strengths
- Specialization in a segment of innovative microbiotic therapies
- Disruptive potential in treating severe diseases through the microbiome
- Rooted in advanced medical research in biotechnology
Weaknesses
- Historically volatile stock performance with a significant decline in the medium and long term
- Lack of recent news enhancing visibility to investors
Momentum
The current momentum reveals a resurgence of interest with notable progress over the past six months, suggesting a phase of recovery after several years of negative performance. This dynamic encourages monitoring clinical and commercial developments to confirm the viability of the model in the medium term.
Similar stocks to MaaT Pharma
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
